Giving prescription glasses to improve vision and thinking in rural older adults
Official title: The Impact of Spectacle Intervention for Refractive Error and Presbyopia on Cognitive Function in Rural Older Adults
Run by Sichuan University · NCT06836440 · Data updated 2026-11-12
This project will test whether giving free prescription glasses to rural adults aged 60–79 with correctable vision problems can slow thinking and memory decline over 36 months.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years to 79 Years |
| Sex | All |
| Enrollment | 964 (estimated) |
| Sponsor | Sichuan University Academic / other |
| Locations | 1 site (Ya'an, Sichuan) |
| Status | Recruiting |
| Started | November 10, 2025 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2030 |
| Registry record updated | September 14, 2026 |
| Trial ID | NCT06836440 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are rural residents aged 60–79 with distance and/or near vision that improves to normal with spectacles, intact baseline cognition and hearing per C-MMSE cutoffs, and who plan to remain in the local area for the study period.
✕Probably not a fit
Patients with uncorrectable eye disease, existing cognitive impairment beyond the C-MMSE cutoffs, severe hearing loss, or who cannot use spectacles are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional project provides free prescription near and/or distance glasses to eligible rural older adults and compares their cognitive change over 36 months with a comparison group that does not receive refractive correction. Eligible participants are community-dwelling residents aged 60–79 in Ya'an, Sichuan, who have correctable vision impairment and normal baseline cognition and hearing by C-MMSE cutoffs. Cognitive decline rates will be measured repeatedly over 36 months and the analysis will include cost-effectiveness of the glasses intervention. The work is delivered through local community health service centers and focuses on scalable, low-cost vision correction.
Why it matters
Potential benefit: If successful, providing affordable, correctable vision correction could slow cognitive decline and offer a low-cost, widely scalable benefit for older adults.
How similar studies have gone: Observational studies have linked better eyesight to improved cognitive test performance, but there are few long-term randomized or interventional trials showing definitive cognitive slowing from vision correction.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Older adults who meet all of the following criteria will be eligible to participate in this study: * Registered as a rural resident (holding rural household registration); * Age from 60 to 79 years at the time of enumeration; * Resident in the household for \> = 3 months and planning to reside in the local area for the trial duration; * Distance vision impairment (VI, presenting visual acuity \[VA\] \< 6/12 in the better-seeing eye and improving to ≥ 6/7.5 or better in either eye with spectacle correction) and/or near VI (presenting near VA \< 6/12 at 40 cm when measured binocularly and improving to ≥ 6/7.5 or better in either eye with near correction); * Independent mobility with or without the support of a walking stick; * Chinese version of the Mini-Mental State Examination (C-MMSE) score above the following cut-offs (out of 30): \>17 for illiterate participants, \>20 for those with primary school education, \>22 for those with junior high school education, and \>23 for those with high school education or above. * Willingness to participate, to be randomized to either study group, and to adhere to the protocol Exclusion Criteria: * Presence of glaucoma or visually significant cataract, or a history of surgical treatment for these or other major ocular conditions; * Consistent use of prescription spectacles and/or hearing aids; * Serious medical illness likely to result in loss to follow-up. Those less severely affected by conditions such as hypertension and/or diabetes will be eligible; * Failure on the whispered voice hearing screening test in the better ear (unable to repeat \> = 3 out of 6 words whispered from behind the participant at a distance of 50 cm);
Where it's running
-
Community health service centers
Ya'an, Sichuan, China Recruiting
Study contacts
- Study coordinator: Yuju Wu
- Email: yujuwu@scu.edu.cn
- Phone: 86+18382096899
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Norms for a Voice-Based Digital Cognitive Test Across Ages
This study tests a voice-enabled digital cognitive test to establish normal scores for adults aged 18–100.
-
Non-invasive brain stimulation plus computer-based memory training for mild cognitive impairment
This trial will test whether a short course of non-invasive brain stimulation combined with one of two computer-based brain-training programs helps people aged 60–85 with mild cognitive impairment improve memory, thinking, mood, and daily function.
-
Westlake Aging Cohort: following 55+ to map aging and cognitive changes
A large observational study in Hangzhou will follow 2,800 adults aged 55–90 to see how aging, cognition, and neurodegenerative diseases relate to biology over time.
-
Predicting Delirium Risk After Heart Surgery Using a New Cognitive Tool
This study is testing a new app to see if it can help doctors predict which older patients are at risk of developing confusion after heart surgery.
-
Trazodone for older adults with major depression and mild cognitive impairment in Italy, Poland, and Romania
This will see if prolonged-release trazodone helps people aged 55+ with major depressive disorder and mild cognitive impairment when prescribed in routine care in Italy, Poland, and Romania.
-
L-Arginine for thinking and memory in older adults
This trial will try whether taking 6 grams of L-arginine once daily for four weeks improves thinking and memory in people over 60 with mild-to-moderate cognitive impairment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.